Online Courses (English)
This just in:

State PCS

Daily Updates

International Relations

India, U.S. to Collaborate on Covid-19 Vaccine Trials

  • 20 May 2020
  • 2 min read

Why in News

India and the U.S. plan to work together on vaccine research and testing for Covid-19.

Key Points

  • Vaccine Action Programme (VAP):
    • In the context of the current pandemic, partners under the Vaccine Action Programme (VAP) are planning to collaborate on the development and testing of vaccine candidates and diagnostics for Covid-19.
    • The Indo-U.S. Vaccine Action Program, is a 33-year collaboration between the U.S. National Institutes of Health, the Indian Department of Biotechnology (DBT) and the Indian Council of Medical Research (ICMR) along with other partners.
    • Focus is on safe, cost-effective vaccines against a range of infectious diseases.
  • Other Initiatives:
    • 50 ventilators from the U.S. are expected in India shortly, as part of the donation of 200 ventilators announced by the US President.
      • It will be paid for by the U.S. Agency for International Development (USAID), as part of $5.9 million funding announced to date for India.
    • The U.S. Centres for Disease Control and Prevention said it would separately fund the Government of India (GoI) $3.6 million to support “prevention, preparedness, and response activities in India, in collaboration with and concurrence from the GoI.”
    • India has exported antimalarial drug Hydroxychloroquine (HCQ) to the U.S. and several other countries.

Source: TH

SMS Alerts
 

Please login or register to view note list

close

Please login or register to list article as bookmarked

close
 

Please login or register to make your note

close

Please login or register to list article as progressed

close

Please login or register to list article as bookmarked

close